Cite
The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
MLA
Parr, Jeremy R., et al. “The Drooling Reduction Intervention Trial (DRI): A Single Blind Trial Comparing the Efficacy of Glycopyrronium and Hyoscine on Drooling in Children with Neurodisability.” Trials, vol. 15, no. 1, Mar. 2014, pp. 1–17. EBSCOhost, https://doi.org/10.1186/1745-6215-15-60.
APA
Parr, J. R., Weldon, E., Pennington, L., Steen, N., Williams, J., Fairhurst, C., O’Hare, A., Lodh, R., & Colver, A. (2014). The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability. Trials, 15(1), 1–17. https://doi.org/10.1186/1745-6215-15-60
Chicago
Parr, Jeremy R., Emma Weldon, Lindsay Pennington, Nick Steen, Jane Williams, Charlie Fairhurst, Anne O’Hare, Raj Lodh, and Allan Colver. 2014. “The Drooling Reduction Intervention Trial (DRI): A Single Blind Trial Comparing the Efficacy of Glycopyrronium and Hyoscine on Drooling in Children with Neurodisability.” Trials 15 (1): 1–17. doi:10.1186/1745-6215-15-60.